Vincent Herbst, MD
Procedural Dermatology · Williamsport, PANPI 1447218466
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 30.5% of the total.
Across 240 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$746
- Regeneron Healthcare Solutions, Inc.$455
- Sun Pharmaceutical Industries Inc.$349
- Novartis$290
- Amgen$273
- plus $519 from 4 others
What the payments were for
- Food & beverage$3,52493%
- Education$2657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,157 |
| Johnson & Johnson | 49 | $746 |
| Regeneron Healthcare Solutions, Inc. | 31 | $455 |
| Sun Pharmaceutical Industries Inc. | 16 | $349 |
| Novartis | 11 | $290 |
| Amgen | 17 | $273 |
| Pfizer | 19 | $248 |
| Lilly USA, LLC | 14 | $204 |
| Galderma Laboratories, L.p. | 2 | $36 |
| LEO Pharma Inc. | 2 | $30 |
How this compares
$3,790 in reported general payments places this provider in the 80th percentile of 26 procedural dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 23 | $169,314 |
| Humira(Cf) PenAdalimumab | 18 | $136,929 |
| Clobetasol Propionate | 164 | $6,406 |
| Acitretin | 14 | $6,085 |
| Fluorouracil | 56 | $3,484 |
| Doxycycline Hyclate | 138 | $3,483 |
| Betamethasone Dipropionate | 66 | $3,213 |
| Triamcinolone Acetonide | 183 | $2,791 |
| Metronidazole | 59 | $2,440 |
| Imiquimod | 100 | $1,768 |
| Minocycline Hcl | 47 | $1,447 |
| Ketoconazole | 96 | $1,273 |
| Fluocinonide | 28 | $966 |
| ValacyclovirValacyclovir Hcl | 47 | $918 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 24 | $792 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Williamsport
- Jonathan WolfePlymouth Meeting$252K
- Stuart GlasserGreensburg$13K
- Danielle DehoratiusBryn Mawr$12K
- Anthony SantoroDoylestown$8K
- Barbara MathesPhiladelphia$7K
- Elizabeth AndersonCamp Hill$3K
- John BartonEnola$2K
- Anne AngelesPhiladelphia$2K
- Louis BrownPhiladelphia$1K
- Carol NeishPittsburgh$518
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.